Exploring the Future of Psychedelic Medicine: An Entrepreneur's Journey with Greg McKee
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Exploring the Future of Psychedelic Medicine: An Entrepreneur's Journey with Greg McKee
-
ナレーター：
-
著者：
このコンテンツについて
In this episode host Ross O'Brien from Bonaventure Equity interviews Greg McKee, the founder and CEO of Journey Life Sciences and a managing partner at Bonaventure Equity. O'Brien and McKee discuss the emerging world of psychedelics and venture capital, and the need for new paradigms of medicine to address the mental health, addiction, and pain epidemics. They talk about entrepreneurship and the importance of testing the market demand for new ideas, especially in the context of psychedelics as potential therapeutics. McKee shares his background in finance and drug development, and how he came to be interested in psychedelics. The episode concludes with a discussion of Journey's mission and how the company is working to bring psychedelic therapies to market.
Produced by PodConX
Ross O'Brien - https://www.linkedin.com/in/rossobrien/
Bonaventure Equity - https://link.bve.vc/Visit-Us
Greg McKee - https://www.linkedin.com/in/gregorymmckee/